ABIRANAT Tablets 250 Tanzania - English - Tanzania Medicinces & Medical Devices Authority

abiranat tablets 250

natco pharma limited, india - abiraterone acetate - tablets - 250

EVEROLIMUS tablet United States - English - NLM (National Library of Medicine)

everolimus tablet

natco pharma limited - everolimus (unii: 9hw64q8g6g) (everolimus - unii:9hw64q8g6g) - everolimus tablets are indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, her2-negative breast cancer in combination with exemestane, after failure of treatment with letrozole or anastrozole. everolimus tablets are indicated for the treatment of adult patients with progressive neuroendocrine tumors of pancreatic origin (pnet) with unresectable, locally advanced or metastatic disease. everolimus tablets are indicated for the treatment of adult patients with progressive, well-differentiated, non-functional net of gastrointestinal (gi) or lung origin with unresectable, locally advanced or metastatic disease. limitations of use:  everolimus tablets are not indicated for the treatment of patients with functional carcinoid tumors [see clinical studies (14.2)] . everolimus tablets are indicated for the treatment of adult patients with advanced rcc after failure of treatment with sunitinib or sorafenib. everolimus tablets are indicated for the treatment of adult patients wi

TRIHEXYPHENIDYL HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

trihexyphenidyl hydrochloride tablet

natco pharma limited - trihexyphenidyl hydrochloride (unii: ao61g82577) (trihexyphenidyl - unii:6rc5v8b7po) - trihexyphenidyl hydrochloride 2 mg - trihexyphenidyl hcl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). it is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.  trihexyphenidyl hcl is contraindicated in patients with hypersensitivity to trihexyphenidyl hcl or to any of the tablet ingredients. trihexyphenidyl hcl is also contraindicated in patients with narrow angle glaucoma. blindness after long-term use due to narrow angle glaucoma has been reported. although trihexyphenidyl hcl is not classified as a controlled substance, the possibility of abuse should be borne in mind due to its stimulant and euphoriant properties.

BEMUNAT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MGVIAL USP Singapore - English - HSA (Health Sciences Authority)

bemunat powder for concentrate for solution for infusion 100 mgvial usp

natco pharma asia pte. ltd. - bendamustine hydrochloride - injection, powder, lyophilized, for solution - bendamustine hydrochloride 100.00 mg

BEMUNAT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 25 MGVIAL USP Singapore - English - HSA (Health Sciences Authority)

bemunat powder for concentrate for solution for infusion 25 mgvial usp

natco pharma asia pte. ltd. - bendamustine hydrochloride - injection, powder, lyophilized, for solution - bendamustine hydrochloride 25.00mg